Home News Issues My AVMA Jobs Animal Health Public Health @Work Blog Newsletters
Search Tips | Advanced Search     Bookmark and Share
  
 
Search within Advocacy only.

National Issues

Congressional Activities



Federal Regulatory Activities



Other National Activities

 

State Issues

State legislative resources

 

Get involved

About AVMAPAC



AVMA-CAN Government
Action Center



AVMA fellowships



Student externships


Newsletters

The AVMA Advocate



AccessPAC

 

AVMA Member area = AVMA/SAVMA  Members Only


Get Adobe reader

Some files on this page require Adobe Reader software. Click on the image above to download it for free from the Adobe site.

 




 
Federal regulatory practice issues: Vaccines

Including specific leptospiral serovar(s) on canine vaccine labels
Formal title:
USDA Center for Veterinary Biologics (CVB) Draft Notice No. D011: True Name Change for Canine Vaccines with Bacterins Containing Leptospira

View document on USDA Web site (PDF, 221Kb)

Summary

The USDA Center for Veterinary Biologics proposes that all licenses, Outlines of Production, and labels for canine products containing Leptospira serovars will bear a True Name identifying each Leptospira serovar in the product, no later than October 1, 2008. Heretofore, labels did not specify the serovar.

The AVMA believes it is important for veterinarians to be able to identify a product's leptospiral serovars in order to make customized, science-based vaccination recommendations to dog owners.

The AVMA supports this CVB proposal and encourages further proposals that add clinically relevant, science-based content to biologic product labels.

Response
View AVMA response to USDA (PDF)
Conclusion
The USDA concluded that each Leptospira serovar contained in a biologic product will be identified in the product's True Name. Furthermore, acceptable abbreviations for four Leptospira serovars were identified.

View USDA conclusion (PDF, 24 Kb).